| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | May 14, 2025 | INSULET CORP | Director | Sell | 17.5 | -5,235 | -16.28% | ✗ | $1.7M |
| Sep 11, 2024 | Sep 12, 2024 | INSULET CORP | Director | Sell | 17.5 | -7,628 | -22.08% | ✗ | $1.7M |
| May 13, 2024 | May 14, 2024 | Editas Medicine, Inc. | Director | Buy | 97.5 | +45,000 | 198.24% | ✗ | $253.9K |
| Mar 3, 2021 | Mar 5, 2021 | Editas Medicine, Inc. | Director | Buy | 97.5 | +5,800 | 34.32% | ✗ | $264K |
| Nov 24, 2020 | Nov 25, 2020 | MARAVAI LIFESCIENCES HOLDINGS, INC. | Director | Buy | 100.0 | +50,000 | 421.87% | ✗ | $1.4M |
| Mar 5, 2019 | Mar 7, 2019 | Editas Medicine, Inc. | Director | Buy | 95.0 | +10,200 | 152.24% | ✗ | $244.2K |
| May 17, 2018 | May 21, 2018 | Editas Medicine, Inc. | Director | Buy | 95.0 | +6,700 | 100.00% | ✗ | $249.8K |
| May 11, 2017 | May 12, 2017 | INSULET CORP | Director | Buy | 95.0 | +2,580 | 20.40% | ✗ | $99.8K |
| Mar 2, 2016 | Mar 3, 2016 | INSULET CORP | Director | Buy | 95.0 | +3,230 | 57.60% | ✗ | $99.8K |